samedan logo

 
 
spacer
home > pmps > spring 2009 > supply chain strategies
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Supply Chain Strategies

In the pharmaceutical industry, companies face challenges ranging from margin pressures and rising costs to complex regulatory environments and growing competition – and increasingly, they are viewing the supply chain as a key ingredient in meeting those challenges successfully. With that in mind, the 2008-2009 ‘Global Pharma Industry Supply Chain & Tech Ops Study’ was conducted in order to develop a deeper understanding of the nature and evolution of the supply chain in the industry. The study involved 17 pharmaceutical and biotech companies across a variety of business segments and geographies, and was conducted under the guidance of a steering committee made up of major pharmaceutical manufacturers. By drawing on the experiences of industry participants, it aimed to provide a practical perspective that can help companies strengthen their ability to use the supply chain as a key driver of high performance.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.

spacer

Jay Welsh is a partner in Accenture’s Pharmaceutical & Medical Products Supply Chain practice out of the firm’s Boston office. He is the global lead for Accenture’s Clinical Supplies practice and Supply Chain Merger Integration practice. Jay is also the executive sponsor for the 2008 Pharmaceutical Industry Best Practices Study in Technical Operations & Supply Chain. Focusing on supply chain strategy, R&D, technical operations and merger integration, he has teamed up with both large and small pharma and biotech clients to reduce costs, increase revenues, improve customer service and drive strategic advantages within the marketplace.

spacer
Jay Welsh
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

The Thermo Fisher Scientific TaqPath COVID-19 CE-IVD RT-PCR Kit Now Available for the Incoming International Travel Quarantine Protocol Testing in the United Kingdom

INCHINNAN, Scotland, May 27, 2021 /PRNewswire/ – Thermo Fisher Scientific, the world leader in serving science, today announced that its TaqPath COVID-19 CE-IVD RT PCR Kit has been independently validated as meeting the performance characteristics for the Day 2 and Day 8 COVID-19 quarantine protocol testin.
More info >>

White Papers

Translating Cancer Genomics Into A Personalised Approach For Cancer Patients

PRA Health Sciences (PRA)

Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patient’s particular disease at a precise time point) is being performed every day at different levels in the clinical setting.
More info >>

 
Industry Events

A Magic Triangle: Practical insights into lactose-based DPI formulations

30 June 2021, Online webinar

Three leading companies with complementary areas of expertise have joined forces to conduct a unique multidisciplinary study into lactose-based DPI formulations including magnesium stearate. Their findings will give generic players a head start in the development process so that they can tap into this rapidly growing market. Lactose specialist DFE Pharma, powder processing technology manufacturer Hosokawa Micron and machine-building expert Harro Hoefliger will be presenting the key insights from their research to interested parties during a joint webinar on the 30th of June.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement